Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Zaltzman

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|March 10, 2009
Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular riskFarah Bandukwala, Michael Huang, Jeffrey S Zaltzman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 28, 2014
A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteersJeffrey S Zaltzman, Vesta Lai, Miklos Z Schulz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1996
Accurate measurement of impaired glomerular filtration using single-dose oral cimetidineJ S Zaltzman, C Whiteside, D C Cattran, et al.
Case Reports in Pathology|October 11, 2014
A clinical and pathological variant of acute transplant glomerulopathyMiklos Z Molnar, G V Ramesh Prasad, Darren A Yuen, et al.
Transplantation|November 15, 2006
Outcomes of commercial renal transplantation: a Canadian experienceG V Ramesh Prasad, Ashutosh Shukla, Michael Huang, et al.
Kidney International|April 17, 2016
Commercial kidney transplantation is an important risk factor in long-term kidney allograft survivalG V Ramesh Prasad, Sailesh Ananth, Sneha Palepu, et al.
Transplantation Research|March 11, 2014
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicityLauren Glick, Fernanda Shamy, Michelle Nash, et al.
BMC Nephrology|March 6, 2022
Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneysAtit A Dharia, Michael Huang, Michelle M Nash, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 1, 1980
[Management of patients with chronic renal failure in the Instituto Nacional de Pediatria, D.I.F. (author's transl)]S Zaltzman, O Ruiz Speare, A Guzmán Flores, et al.
Canadian Journal of Kidney Health and Disease|April 28, 2016
Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort studyTess Montada-Atin, Diana Choi, Minna Woo, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|March 10, 2009
Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular riskFarah Bandukwala, Michael Huang, Jeffrey S Zaltzman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 28, 2014
A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteersJeffrey S Zaltzman, Vesta Lai, Miklos Z Schulz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1996
Accurate measurement of impaired glomerular filtration using single-dose oral cimetidineJ S Zaltzman, C Whiteside, D C Cattran, et al.
Case Reports in Pathology|October 11, 2014
A clinical and pathological variant of acute transplant glomerulopathyMiklos Z Molnar, G V Ramesh Prasad, Darren A Yuen, et al.
Transplantation|November 15, 2006
Outcomes of commercial renal transplantation: a Canadian experienceG V Ramesh Prasad, Ashutosh Shukla, Michael Huang, et al.
Kidney International|April 17, 2016
Commercial kidney transplantation is an important risk factor in long-term kidney allograft survivalG V Ramesh Prasad, Sailesh Ananth, Sneha Palepu, et al.
Transplantation Research|March 11, 2014
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicityLauren Glick, Fernanda Shamy, Michelle Nash, et al.
BMC Nephrology|March 6, 2022
Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneysAtit A Dharia, Michael Huang, Michelle M Nash, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 1, 1980
[Management of patients with chronic renal failure in the Instituto Nacional de Pediatria, D.I.F. (author's transl)]S Zaltzman, O Ruiz Speare, A Guzmán Flores, et al.
Canadian Journal of Kidney Health and Disease|April 28, 2016
Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort studyTess Montada-Atin, Diana Choi, Minna Woo, et al.
Pageof 8